Official scientific distribution organ of Instituto Panvascular de Occidente
Gallbladder Hodgkin Lymphoma: A Rare Case Report
PDF Reporte de Caso (Spanish)

Keywords

Hodgkin Lymphoma
Gallbladder
Acute myeloblastic leukemia

Categories

How to Cite

1.
Gallbladder Hodgkin Lymphoma: A Rare Case Report. Rev Med Clin [Internet]. 2023 Oct. 20 [cited 2024 Jul. 3];7(3):e20102307024. Available from: https://medicinaclinica.org/index.php/rmc/article/view/534

Abstract

We present an 81-year-old patient with a history of Acute Myeloblastic Leukemia treated 3 years earlier with the fludarabine, filgrastim and cytarabine regimen according to the 2014 Spanish Hematology Treatment Program regimen, with minimal residual disease negative after finishing treatment one year later. who went to the emergency room due to febrile syndrome and signs of acute cholecystitis, for which antibiotic therapy was started. 24 hours later, the evolution was unfavorable, so he was admitted to intensive care, an open cholecystectomy with Blake drainage was performed, however, the clinical worsening continued, and he died 72 hours later. The pathology results of the gallbladder showed lymphangitic infiltration by cells with atypia and expression of CD30, PAX5 and EBV-LMP1, concluding the diagnosis of gallbladder with infiltration by classic Hodgkin lymphoma. It is important to highlight that in the previously received treatment scheme, especially fludarabine, it produces significant myelosuppression and intense lymphopenia that has been related to the development of secondary neoplasms of both solid organs, leukemias, or lymphoproliferative syndromes. In conclusion, we believe that first of all patients with a history of chemotherapy treatment, the possibility of a second neoplasia should be taken into account in the differential diagnosis.

PDF Reporte de Caso (Spanish)

References

Manesh M, Henry R, Gallagher S, Greas M, Sheikh MR, Zielsdorf S. Hodgkin lymphoma masquerading as perforated gallbladder adenocarcinoma: A case report. World J Gastrointest Surg [Internet]. 2021;13(10):1279–84. Disponible en: http://dx.doi.org/10.4240/wjgs.v13.i10.1279

Nasiri AM, Alshammari M, Ahmed A, Elsir B, Alghethber H. Primary hepatic Hodgkin’s lymphoma: A case report. J Family Med Prim Care [Internet]. 2022; 11(3):1184–7. Disponible en: http://dx.doi.org/10.4103/jfmpc.jfmpc_1116_21

LaCasce A. Hodgkin lymphoma: Epidemiology and risk factor. [Internet]. Waltham (MA): UpToDate 2023 [citado el 1 de febrero 2023]. Disponible en: http://uptodate.com/

LaCasce A. Clinical presentation and diagnosis of classic Hodgkin lymphoma in adults. [Internet]. Waltham (MA): UpToDate 2023 [citado el 1 de febrero 2023]. Disponible en: http://uptodate.com/

Lukenbill J, Kalaycio M. Fludarabine: a review of the clear benefits and potential harms. Leuk Res [Internet]. 2013;37(9):986–94. Disponible en: http://dx.doi.org/10.1016/j.leukres.2013.05.004

Ministerio de Sanidad Gobierno de España. Agencia española de medicamentos y productos sanitarios [Internet]. España [revisado; 2 de febrero 2023]. Disponible en: https://www.aemps.gob.es/#

Singh R, Sheikh S, Pallagatti S, Aggarwal A, Gupta D, Handa R, et al. Lymphocyte depleted Hodgkin’s lymphoma presented with Haemolytic Anemia: A case report and literature review. J Maxillofac Oral Surg [Internet]. 2015;14(Suppl 1):317–22. Disponible en: http://dx.doi.org/10.1007/s12663-013-0528-1

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Miguel Osorio-Manyari, Martha Mosquera-T, Pilar Galán-A

Downloads

Download data is not yet available.